Suppose to be 21 here today and 24 tomorrow.
The fog has to burn off first.
I have been adding here and there. I still think it is a good buy in the twenties. The launch from Covidien should be this quarter. It is already undervalued at a diluted EPS of $0.04. But at the moment the market only believes it is worth a little north of a quarter.
